Neurofibroma pathophysiology: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 24: Line 24:


==Microscopic Pathology==
==Microscopic Pathology==
Features:
*Spindle cells with wavy nuclei without pleomorphism - '''key feature'''.
*Intermixed with wire-like collagen.
**Often no pattern is apparent.
**Often described as "shredded carrots".<ref name=pmid24216989>{{Cite journal  | last1 = Bernthal | first1 = NM. | last2 = Jones | first2 = KB. | last3 = Monument | first3 = MJ. | last4 = Liu | first4 = T. | last5 = Viskochil | first5 = D. | last6 = Randall | first6 = RL. | title = Lost in translation: ambiguity in nerve sheath tumor nomenclature and its resultant treatment effect. | journal = Cancers (Basel) | volume = 5 | issue = 2 | pages = 519-28 | month =  | year = 2013 | doi = 10.3390/cancers5020519 | PMID = 24216989 }}</ref>
*Moderate increase of cellularity vis-a-vis normal dermis.
*May be poorly or well-circumscribed.
*+/-Plexiform growth pattern - "bag of worms".<ref name=pmid17893219/>
**Multiple well-circumscribed nests.
*Mast cells<ref name=pmid20233971>{{Cite journal  | last1 = Staser | first1 = K. | last2 = Yang | first2 = FC. | last3 = Clapp | first3 = DW. | title = Mast cells and the neurofibroma microenvironment. | journal = Blood | volume = 116 | issue = 2 | pages = 157-64 | month = Jul | year = 2010 | doi = 10.1182/blood-2009-09-242875 | PMID = 20233971 }}</ref> - one has to look for them at high power.
**Very useful for confirming the low power suspicion.


==Genetics==
==Genetics==

Revision as of 21:06, 13 November 2015

Neurofibroma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Neurofibroma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Neurofibroma pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Neurofibroma pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Neurofibroma pathophysiology

CDC on Neurofibroma pathophysiology

Neurofibroma pathophysiology in the news

Blogs on Neurofibroma pathophysiology

Directions to Hospitals Treating Neurofibroma

Risk calculators and risk factors for Neurofibroma pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shanshan Cen, M.D. [2]

Overview

Pathogenesis

Gross Pathology

Localised neurofibroma/Diffuse neurofibroma[4]

  • Superficial mass
  • Not encapsulated

Plexiform neurofibroma[5]

  • "Bag of worms" appearance

Microscopic Pathology

Features:

  • Spindle cells with wavy nuclei without pleomorphism - key feature.
  • Intermixed with wire-like collagen.
    • Often no pattern is apparent.
    • Often described as "shredded carrots".[8]
  • Moderate increase of cellularity vis-a-vis normal dermis.
  • May be poorly or well-circumscribed.
  • +/-Plexiform growth pattern - "bag of worms".[9]
    • Multiple well-circumscribed nests.
  • Mast cells[10] - one has to look for them at high power.
    • Very useful for confirming the low power suspicion.

Genetics

References

  1. Muir D, Neubauer D, Lim IT, Yachnis AT, Wallace MR. (2003). "Tumorigenic properties of neurofibromin-deficient neurofibroma Schwann cells". American Journal of Pathology. 158 (2): 501–13. doi:10.1016/S0002-9440(10)63992-2. PMC 1850316. PMID 11159187.
  2. Neurofibroma. Wikipedia 2015. https://en.wikipedia.org/wiki/Neurofibroma#cite_note-Yamashiroya2002-3
  3. Mautner VF, Friedrich RE, von Deimling A, Hagel C, Korf B, Knöfel MT, Wenzel R, Fünsterer C. (2003). "Malignant peripheral nerve sheath tumours in neurofibromatosis type 1: MRI supports the diagnosis of malignant plexiform neurofibroma". American Journal of Pathology. 45 (9): 618–25. doi:10.1007/s00234-003-0964-6. PMID 12898075.
  4. Neurofibroma. Dr Bruno Di Muzio and Dr Maxime St-Amant et al. Radiopaedia.org 2015. http://radiopaedia.org/articles/neurofibroma
  5. Wilkinson LM, Manson D, Smith CR (2004). "Best cases from the AFIP: plexiform neurofibroma of the bladder". Radiographics : a Review Publication of the Radiological Society of North America, Inc. 24 Suppl 1: S237–42. doi:10.1148/rg.24si035170. PMID 15486243. Retrieved 2015-11-13.
  6. Neurofibroma. Libre Pathology 2015. http://librepathology.org/wiki/index.php/Neurofibroma#cite_note-pmid15486243-2
  7. Neurofibroma. Libre Pathology 2015. http://librepathology.org/wiki/index.php/Neurofibroma#cite_note-pmid15486243-2
  8. Bernthal, NM.; Jones, KB.; Monument, MJ.; Liu, T.; Viskochil, D.; Randall, RL. (2013). "Lost in translation: ambiguity in nerve sheath tumor nomenclature and its resultant treatment effect". Cancers (Basel). 5 (2): 519–28. doi:10.3390/cancers5020519. PMID 24216989.
  9. Staser, K.; Yang, FC.; Clapp, DW. (2010). "Mast cells and the neurofibroma microenvironment". Blood. 116 (2): 157–64. doi:10.1182/blood-2009-09-242875. PMID 20233971. Unknown parameter |month= ignored (help)
  10. Kluwe L, Friedrich R, Mautner VF (1999). <283::AID-GCC15>3.0.CO;2-K "Loss of NF1 allele in Schwann cells but not in fibroblasts derived from an NF1-associated neurofibroma". Genes, Chromosomes & Cancer. 24 (3): 283–5. PMID 10451710. Retrieved 2015-11-13.


Template:WikiDoc Sources